Prolabin&Tefarm and the University of Perugia sign a contract for the co-financing of a Type A RTD entitled: “Design and development of broad spectrum virucidal agent to counteract the spread of pandemic and neglected viruses” (2021-2024) .

Collaboration with Dr. TOMMASO FELICETTI and supervision by Prof. GIUSEPPE MANFRONI of the Department of Pharmaceutical Sciences – Section of Medicinal Chemistry and Technology.

The aim of the study is to search for new solutions to meet the needs of emerging, current and future viral diseases through the development of broad-spectrum antivirals.

Once again, the company hopes that the strong link between the academic and business worlds will lead to effective and concrete solutions.